These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 28287172)
1. Killing of Staphylococcus aureus and Salmonella enteritidis and neutralization of lipopolysaccharide by 17-residue bovine lactoferricins: improved activity of Trp/Ala-containing molecules. Hao Y; Yang N; Wang X; Teng D; Mao R; Wang X; Li Z; Wang J Sci Rep; 2017 Mar; 7():44278. PubMed ID: 28287172 [TBL] [Abstract][Full Text] [Related]
3. Antibacterial and detoxifying activity of NZ17074 analogues with multi-layers of selective antimicrobial actions against Escherichia coli and Salmonella enteritidis. Yang N; Liu X; Teng D; Li Z; Wang X; Mao R; Wang X; Hao Y; Wang J Sci Rep; 2017 Jun; 7(1):3392. PubMed ID: 28611436 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of a 2-arylsulphonylated tryptophan: the antibacterial activity of bovine lactoferricin peptides containing Trp(2-Pmc). Haug BE; Andersen J; Rekdal O; Svendsen JS J Pept Sci; 2002 Jul; 8(7):307-13. PubMed ID: 12148780 [TBL] [Abstract][Full Text] [Related]
5. Synthetic Peptides Derived from Bovine Lactoferricin Exhibit Antimicrobial Activity against E. coli ATCC 11775, S. maltophilia ATCC 13636 and S. enteritidis ATCC 13076. Huertas Méndez NJ; Vargas Casanova Y; Gómez Chimbi AK; Hernández E; Leal Castro AL; Melo Diaz JM; Rivera Monroy ZJ; García Castañeda JE Molecules; 2017 Mar; 22(3):. PubMed ID: 28287494 [TBL] [Abstract][Full Text] [Related]
6. Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans. Chen HL; Yen CC; Lu CY; Yu CH; Chen CM J Agric Food Chem; 2006 May; 54(9):3277-82. PubMed ID: 16637685 [TBL] [Abstract][Full Text] [Related]
7. Structural studies and model membrane interactions of two peptides derived from bovine lactoferricin. Nguyen LT; Schibli DJ; Vogel HJ J Pept Sci; 2005 Jul; 11(7):379-89. PubMed ID: 15635665 [TBL] [Abstract][Full Text] [Related]
8. Comparative antimicrobial activity and mechanism of action of bovine lactoferricin-derived synthetic peptides. Liu Y; Han F; Xie Y; Wang Y Biometals; 2011 Dec; 24(6):1069-78. PubMed ID: 21607695 [TBL] [Abstract][Full Text] [Related]
9. Bactericidal kinetics of 3 lactoferricins against Staphylococcus aureus and Escherichia coli. Ulvatne H; Vorland LH Scand J Infect Dis; 2001; 33(7):507-11. PubMed ID: 11515760 [TBL] [Abstract][Full Text] [Related]
10. Contribution of bovine lactoferrin inter-lobe region to iron binding stability and antimicrobial activity against Staphylococcus aureus. Bai X; Teng D; Tian Z; Zhu Y; Yang Y; Wang J Biometals; 2010 Jun; 23(3):431-9. PubMed ID: 20145976 [TBL] [Abstract][Full Text] [Related]
11. The role of tryptophan in the antibacterial activity of a 15-residue bovine lactoferricin peptide. Haug BE; Svendsen JS J Pept Sci; 2001 Apr; 7(4):190-6. PubMed ID: 11354462 [TBL] [Abstract][Full Text] [Related]
12. Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin. Vorland LH; Ulvatne H; Andersen J; Haukland H; Rekdal O; Svendsen JS; Gutteberg TJ Scand J Infect Dis; 1998; 30(5):513-7. PubMed ID: 10066056 [TBL] [Abstract][Full Text] [Related]
13. The effects of charge and lipophilicity on the antibacterial activity of undecapeptides derived from bovine lactoferricin. Strøm MB; Rekdal O; Svendsen JS J Pept Sci; 2002 Jan; 8(1):36-43. PubMed ID: 11831560 [TBL] [Abstract][Full Text] [Related]
14. Structure-microbicidal activity relationship of synthetic fragments derived from the antibacterial alpha-helix of human lactoferrin. Håversen L; Kondori N; Baltzer L; Hanson LA; Dolphin GT; Dunér K; Mattsby-Baltzer I Antimicrob Agents Chemother; 2010 Jan; 54(1):418-25. PubMed ID: 19917761 [TBL] [Abstract][Full Text] [Related]
15. Prediction of antibiotic activity and synthesis of new pentadecapeptides based on lactoferricins. Lejon T; Stiberg T; Strøm MB; Svendsen JS J Pept Sci; 2004 Jun; 10(6):329-35. PubMed ID: 15214437 [TBL] [Abstract][Full Text] [Related]
16. Important structural features of 15-residue lactoferricin derivatives and methods for improvement of antimicrobial activity. Strøm MB; Haug BE; Rekdal O; Skar ML; Stensen W; Svendsen JS Biochem Cell Biol; 2002; 80(1):65-74. PubMed ID: 11908644 [TBL] [Abstract][Full Text] [Related]
17. Simple parameterization of non-proteinogenic amino acids for QSAR of antibacterial peptides. Lejon T; Svendsen JS; Haug BE J Pept Sci; 2002 Jul; 8(7):302-6. PubMed ID: 12148779 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial Activity of Truncated and Polyvalent Peptides Derived from the FKCRRQWQWRMKKGLA Sequence against Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 25923. Huertas NJ; Monroy ZJR; Medina RF; Castañeda JEG Molecules; 2017 Jun; 22(6):. PubMed ID: 28613262 [TBL] [Abstract][Full Text] [Related]
19. Fatty acid modified-antimicrobial peptide analogues with potent antimicrobial activity and topical therapeutic efficacy against Staphylococcus hyicus. Liu H; Yang N; Teng D; Mao R; Hao Y; Ma X; Wang X; Wang J Appl Microbiol Biotechnol; 2021 Aug; 105(14-15):5845-5859. PubMed ID: 34319418 [TBL] [Abstract][Full Text] [Related]
20. Enhanced antimicrobial activity of a peptide derived from human lysozyme by arylation of its tryptophan residues. González R; Mendive-Tapia L; Pastrian MB; Albericio F; Lavilla R; Cascone O; Iannucci NB J Pept Sci; 2016 Feb; 22(2):123-8. PubMed ID: 26785822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]